Golden
Grail

Grail

Grail is a biotechnology company headquartered in Menlo Park, California that was founded by Jeffrey Huber, Sjuul van den Eertweg in 2016 focused on making a medical device that can detect early stage cancer.

All edits by  Katsuyuki Hasegawa 

Edits on 17 Oct 2019
Katsuyuki Hasegawa
Katsuyuki Hasegawa edited on 17 Oct 2019 12:35 am
Edits made to:
Article (+16 characters)

Article

On November 22, 2017 Grail closed their series B funding round with $1.2 billion in funding from ARCH Venture Partners, Johnson & Johnson Development Corporation, Dentsu Ventures and Glen Kacher. 

Edits on 2 Aug 2019
Katsuyuki Hasegawa
Katsuyuki Hasegawa edited on 2 Aug 2019 4:18 am
Edits made to:
Timeline (+1 events) (+142 characters)
People (+10/-1 rows) (+20/-2 cells) (+358/-71 characters)
Further reading (+1 rows) (+5 cells) (+257 characters)

People

Name
Role
Related Golden topics

Alex Aravanis

ViceChief PresidentScientific Officer and Head of Research R& Development D



Bill Rastetter

Board of Directors



Catherine Friedman

Board of Directors



Hal Barron

Board of Directors



Hans Bishop

CEO



Jennifer Cook

CEO



Jessica Owens

Vice President of Product Marketing Strategy



Joshua Ofman

Chief of Corporate Strategy and External Affairs



Kaye Foster

Board of Directors



Maykin Ho

Board of Directors



Min Cui

Board of Directors



Richard Klausner

Board of Directors



Robert Nelsen

Board of Directors



Further reading

Title
Author
Link
Type
Date

GRAIL Announces Positive New Data with Multi-Cancer Early Detection Blood Test from CCGA Study

Grail Press Release

News

May 31, 2019

Timeline

May 2019

Thrive Earlier Detection, which raised over $100 million in May, is another company taking the approach of looking at multiple cancer screens.

No more activity to show.